| | |
C.H. Unnikrishnan and Radhieka Pandeya 12:34 AM | April 20,2009
Average growth in sales for the quarter likely to be less than 11%, compared with 14% in the year-ago period
|
|
C.H. Unnikrishnan 11:20 PM | March 26,2009
Multicare, which had sales of 272 million Philippine peso in 2008, is a generic or off-patent drug maker focused on the woman and child health segment in the local market
|
|
C.H. Unnikrishnan 12:19 AM | August 20,2008
Mumbai-based Lupin will use its US subsidiary, Lupin Pharmaceuticals Inc., to promote Forest Laboratories’ inhaling device AeroChamber Plus to paediatricians in the US
|
|
Bhuma Shrivastava 11:10 PM | October 16,2007
One-off opportunities in drug launches and huge foreign currency loans will shield companies such as Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Lupin Ltd and Jubilant Organosys Ltd
|
|
02:21 PM | September 13,2007
Appeals court reverses lower court decision that Lupin had infringed patent owned by Aventis; new ruling means Aventis’ patent is invalid
|
|
Jeetha D’Silva 01:07 AM | July 20,2007
Lupin earned Rs301.8 crore from exports
FIND MORE ARTICLES ON:
Lupin Ltd Quarter results
|
|